Vacha Robin
SEC CIK 1832620 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AZTA | Azenta, Inc. | SVP, GM Life Science Products | 31.3K | — | $1.83M | 14 | 2021-01-31 | 2024-02-01 |
Most active insiders at AZTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cornog William L | Dir | $163.8K | — |
| 2 | Starr Ephraim | SVP, Gen Counsel, Sec | $8,096 | — |
| 3 | Bello Erik J. | VP CAO | — | — |
| 4 | Lin Lawrence Y. | EVP, CFO, Treas | — | — |
| 5 | Pirogova Olga | SVP, CHRO | — | — |
| 6 | Koffey Quentin | Dir | — | — |
| 7 | Zhou Ginger | SVP, GM, Multiomics | — | — |
| 8 | MARTIN WILLIAM E. III | Pres Multiomics | — | — |
| 9 | Casal Frank | Dir | — | — |
| 10 | Marotta John | Pres, CEO, Dir | — | — |
Vacha Robin made no open-market trades at AZTA in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-02 | 2024-01-31 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $53.01 | +151 | 31.4K | +0.5% | +$8,005 | |
| 2024-02-02 | 2024-02-01 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $39.41 | +324 | 31.3K | +1% | +$12.8K | |
| 2023-12-06 | 2023-12-05 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | D - Sale to Iss | $56.60 | -5,175 | 25.8K | -17% | -$292.9K | |
| M | 2023-11-17 | 2023-11-15+ | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $54.36 | +8,689 | 29.3K | +42% | +$472.4K |
| 2023-11-17 | 2023-11-16 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | D - Sale to Iss | $53.81 | -2,946 | 26.4K | -10% | -$158.5K | |
| 2023-08-14 | 2023-08-10 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $55.00 | -7,400 | 25.2K | -23% | -$407.0K | |
| 2023-08-01 | 2023-07-31 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $39.98 | +121 | 32.6K | +0.4% | +$4,838 | |
| 2023-02-02 | 2023-01-31 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $46.92 | +265 | 32.5K | +0.8% | +$12.4K | |
| 2022-11-21 | 2022-11-17 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $0.00 | +3,778 | 32.2K | +13% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $0.00 | +11.1K | 34.3K | +48% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | F - Tax | $0.00 | -5,838 | 28.5K | -17% | $0 | |
| 2022-02-02 | 2022-01-31 | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM Life Science Products | A - Grant | $69.29 | +285 | 23.2K | +1% | +$19.7K | |
| M | 2021-11-19 | 2021-11-17+ | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM BLS-Products | S - Sale | $119.17 | -15.4K | 22.9K | -40% | -$1.83M |
| M | 2021-11-17 | 2021-01-31+ | AZTA | Azenta, Inc. | Vacha Robin | SVP, GM BLS-Products | A - Grant | $0.00 | +19.7K | 37.7K | +110% | $0 |
Purchase Sale Sale after option exercise All abbreviations